CoNextions Medical

Executive Summary

CoNextions Medical is a privately held medical device company headquartered in Minneapolis, MN, focused on developing innovative implants for orthopedic soft tissue repair. Founded in 2016, the company addresses the critical need for superior fixation in tendon-to-bone and tendon-to-tendon repairs, with the goal of simplifying surgical procedures and improving patient outcomes. Its flagship products—the Coronet Soft Tissue Fixation System and the CoNextions TR Tendon Repair System—are designed to provide secure, reproducible fixation while reducing operative complexity. Although specific financial and clinical milestones have not been publicly disclosed, the company's ongoing product development and potential regulatory submissions position it as a notable player in the orthopedic repair space. With a focused product portfolio and a clear unmet need in soft tissue fixation, CoNextions Medical is poised for potential growth pending regulatory approvals and market adoption. However, as a private company with limited public data, near-term revenue visibility remains low, and success hinges on successful commercialization and clinical validation.

Upcoming Catalysts (preview)

• Q2 2026FDA 510(k) clearance for Coronet Soft Tissue Fixation System75% success
• Q3 2026FDA 510(k) clearance for CoNextions TR Tendon Repair System70% success
• Q4 2026Series A or B financing round to support commercialization60% success